It has already been reported that dinaciclib causes mitochondria-dependent apoptosis in osteosarcoma with MCL-1 being the primary target9, and in hepatocellular carcinoma dinaciclib decreases MCL-1 mRNA levels without significantly changing the expression of other BCL-2 proteins10. The gene discussed is MCL1; the disease is hepatocellular carcinoma.